Regulatory Filings • Jan 8, 2019
Regulatory Filings
Open in ViewerOpens in native device viewer
BerGenBio to present company overview at Biotech Showcase 2019 during annual J.P. Morgan Conference in San Francisco
Bergen, Norway, Jan 8th 2019 - BerGenBio ASA (OSE:BGBIO), a clinical-stage
biopharmaceutical company focused on developing a pipeline of first-in-class AXL
kinase inhibitors to treat multiple cancer indications, announces that the
Company will be presenting a corporate overview at the Biotech Showcase 2019
in San Francisco today at 10:00 am PST.
The presentation will webcast live and the presentation is available for
download at the Company's website: www.bergenbio.com/investors/presentations/
Details for the presentation are as follows:
Biotech Showcase
Date: Tuesday, January 8, 2019
Time: 10:00 am PST
Room: Franciscan A (Ballroom Level)
Venue: Hilton San Francisco Union Square Hotel, 333 O'Farrell Street
-Ends-
Contacts
Richard Godfrey, CEO, BerGenBio ASA
+47 917 86 304
Rune Skeie, CFO, BerGenBio ASA
+47 917 86 513
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.